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background: The efficacy of second-generation drug-eluting stent (DES) for the treatment of left main disease (LM) and/or three vessel disease 
(3VD) remains unclear. The aim of this study is to investigate how does the second-generation DES improve clinical outcomes in patients with LM 
and/or 3VD compared with first-generation DES.
Methods: Between April 2008 and January 2013, 326 patients with LM and/or 3VD were treated by percutaneous coronary intervention in 
our institution. 173 patients were treated with first-generation DES and 153 patients were treated with second-generation DES. Target lesion 
revascularization (TLR) and major adverse cardiac events (MACE), defined as cardiac death, non-fatal myocardial infarction, and TLR were compared 
between two groups.
results: The mean follow-up period was 24±18 months. Most of the patient backgrounds were similar between two groups. SYNTAX score between 
two groups were also similar. In the follow-up period, the rates of TLR and MACE were significantly higher in the first-generation DES compared 
with second-generation DES (TLR: 21.2% vs. 7.8%; P<0.001, MACE: 33.4% vs. 11.8%; P<0.001). Kaplan-Meier analysis also revealed that second-
generation DES has favorable results in TLR and MACE (TLR: P=0.012, MACE: P=0.015).
conclusions: Second-generation DES significantly improved TLR and MACE in patients with LM and/or 3VD compared with first-generation DES.
